Custom Phenotypic Assay Development at PhenoVista Biosciences

16 January 2017

Anthony Essex, PhD, Chief Scientific Officer at PhenoVista Biosciences, discusses assay development for high content screening. Learn how PhenoVista's custom iPSC neuronal and T-cell-endothelial assays are more physiologically relevant for enhanced phenotypic screening.